1 Polen Capital Twist Bioscience Trades
Polen Capital's position in Twist Bioscience is currently worth $1.63M. That's 0.01% of their equity portfolio (120th largest holding). The stake costed the investor $1.06M, netting the investor a gain of 53% so far.
News about Twist Bioscience Corp and Polen Capital
Allspring Global Investments Holdings LLC Acquires 1,179 Shares of Twist Bioscience Co. (NASDAQ:TWST)
… the quarter. Allspring Global Investments Holdings LLC’s holdings in … SEC. Several other institutional investors and hedge funds also recently … the perio...
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Twist Bioscience Corporation (TWST)
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming February 10, 2023 deadline to file a lead plaintiff motion i...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Silvergate, Iris, NewAge, and Twist and Encourages Investors to Contact the Firm
NEW YORK, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class ac...
TWIST ALERT: Bragar Eagel & Squire, P.C. is Investigating Twist Bioscience Corp on Behalf of Twist Stockholders and Encourages Investors to Contact the Firm
NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against T...